speb/financial-data huggingface dataset:
Financial ratios for KEI.TO — quarterly report dated 2025-03-31
Total revenue: 21020000
Gross profit: 10082000
Operating income: 8520000
Net income: 5765000
Capital expenditures: 9953000
Operating cash flow: 13007000
Depreciation & amortization: 4063000
Net tangible assets: 195256000
Owner earnings: -125000
Return on net tangible assets (%): -0.06401851927725652
Capex to operating income (%): 116.81924882629109
Buffett classification: The Gruesome
Stock price: 8.398601398601398
P/E ratio: 12.97699078172478
Shares outstanding: 35630862
Book value: 195256000
P/B ratio: 1.5326003166436546
Market cap (USD): 299249407.4265734
Debt to equity: 0.14842053509239153
Current ratio: 0.7045264478360861
Quick ratio: 0.7045264478360861
Effective tax rate (%): 25.57449005938549
Interest coverage ratio: 11.405622489959839
COGS to revenue (%): 52.03615604186489
SG&A to revenue (%): 7.431018078020933
Free cash flow (dilution-adjusted): 2817000
Buyback yield (%): 0.043442024202469974
Retained earnings: -126117000
Receivables turnover: 2.7161131929189817
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6180187525479
FCF margin (%): 13.40152235965747
Rule of 40 score: 13.40152235965747
Financial ratios for KEI.TO — quarterly report dated 2025-06-30
Total revenue: 13790000
Gross profit: 5534000
Operating income: 3564000
Net income: 2853000
Capital expenditures: 16898000
Operating cash flow: 9487000
Depreciation & amortization: 3516000
Net tangible assets: 198393000
Owner earnings: -10529000
Return on net tangible assets (%): -5.307142893146432
Capex to operating income (%): 474.1301907968575
Buffett classification: The Gruesome
Stock price: 6.83941605839416
P/E ratio: 28.277360145883762
Shares outstanding: 35630862
Book value: 198393000
P/B ratio: 1.2283411699869764
Market cap (USD): 243694289.73722625
Debt to equity: 0.15661338857721793
Current ratio: 0.3902427505431189
Quick ratio: 0.3902427505431189
Effective tax rate (%): 24.70308788598575
Interest coverage ratio: 5.56875
COGS to revenue (%): 59.86947063089195
SG&A to revenue (%): 13.756345177664976
Free cash flow (dilution-adjusted): -7899000
Buyback yield (%): 0.21625455424838236
Retained earnings: -123264000
Receivables turnover: 3.76775956284153
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4749030594720312
FCF margin (%): -57.28063814358231
Revenue growth (%): -34.395813510941956
Rule of 40 score: -91.67645165452427
Financial ratios for KEI.TO — quarterly report dated 2025-09-30
Total revenue: 18934000
Gross profit: 7901000
Operating income: 5915000
Net income: 3598000
Capital expenditures: 17369000
Operating cash flow: 6681000
Depreciation & amortization: 4555000
Net tangible assets: 201196000
Owner earnings: -9216000
Return on net tangible assets (%): -4.5806079643730495
Capex to operating income (%): 293.64327979712596
Buffett classification: The Gruesome
Stock price: 5.546762589928058
P/E ratio: 16.17844895125157
Shares outstanding: 35630862
Book value: 201196000
P/B ratio: 0.9823054752007456
Market cap (USD): 197635932.38848922
Debt to equity: 0.23517863178194398
Current ratio: 0.6957989869897706
Quick ratio: 0.6957989869897706
Effective tax rate (%): 25.445503522585994
Interest coverage ratio: 6.646067415730337
COGS to revenue (%): 58.270835533960074
SG&A to revenue (%): 10.151051019330305
Free cash flow (dilution-adjusted): -11200000
Buyback yield (%): 0.5575909130905504
Retained earnings: -119666000
Receivables turnover: 1.9239914642820852
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2580731363738744
FCF margin (%): -59.15284673074892
Revenue growth (%): 37.30239303843364
Rule of 40 score: -21.850453692315277
Financial ratios for KEI.TO — quarterly report dated 2025-12-31
Total revenue: 18349000
Gross profit: 7058000
Operating income: 5081000
Net income: 3261000
Capital expenditures: 18419000
Operating cash flow: 12360000
Depreciation & amortization: 4904000
Net tangible assets: 203876000
Owner earnings: -10254000
Return on net tangible assets (%): -5.029527752163079
Capex to operating income (%): 362.5073804369219
Buffett classification: The Gruesome
Stock price: 3.948905109489051
P/E ratio: 9.091096013910917
Shares outstanding: 35630862
Book value: 203876000
P/B ratio: 0.6901395603567819
Market cap (USD): 140702893.00729927
Debt to equity: 0.24790068472993387
Current ratio: 0.48894398829363467
Quick ratio: 0.48894398829363467
Effective tax rate (%): 18.147590361445783
Interest coverage ratio: 4.20612582781457
COGS to revenue (%): 61.53468853888495
SG&A to revenue (%): 11.21587007466347
Free cash flow (dilution-adjusted): -6566000
Buyback yield (%): 0.1144255079329803
Retained earnings: -116405000
Receivables turnover: 2.273729863692689
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8864632063562783
FCF margin (%): -35.78396642868821
Revenue growth (%): -3.0896799408471534
Rule of 40 score: -38.873646369535365
Financial ratios for KEI.TO — annual report dated 2025-12-31
Total revenue: 72093000
Gross profit: 30575000
Operating income: 23029000
Net income: 15477000
Capital expenditures: 62639000
Operating cash flow: 41535000
Depreciation & amortization: 17038000
Net tangible assets: 203876000
Owner earnings: -30124000
Return on net tangible assets (%): -14.775647942867234
Capex to operating income (%): 272.0005210821139
Buffett classification: The Gruesome
Stock price: 3.948905109489051
P/E ratio: 9.091096013910917
Shares outstanding: 35630862
Book value: 203876000
P/B ratio: 0.6901395603567819
Market cap (USD): 140702893.00729927
Debt to equity: 0.24790068472993387
Current ratio: 0.48894398829363467
Quick ratio: 0.48894398829363467
Effective tax rate (%): 23.927254853772425
Interest coverage ratio: 6.706173558532324
COGS to revenue (%): 57.58950244822659
SG&A to revenue (%): 10.318616231811689
Free cash flow (dilution-adjusted): -22848000
Buyback yield (%): 1.3645774859088333
Retained earnings: -116405000
Receivables turnover: 8.933457249070631
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.550159649513626
FCF margin (%): -31.69239732012817
Revenue growth (%): -3.350225225225225
Rule of 40 score: -35.042622545353396
Financial ratios for LR.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 105.93181818181819
Shares outstanding: 262136090
Market cap (USD): 27768552624.772728
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LR.PA — annual report dated 2022-12-31
Total revenue: 8871702127.659575
Gross profit: 4411382978.723405
Operating income: 1538829787.2340426
Net income: 1063297872.3404256
Capital expenditures: 5319148.936170213
Operating cash flow: 1315106382.9787235
Depreciation & amortization: 408723404.2553192
Net tangible assets: -1558404255.319149
Owner earnings: 1466702127.6595747
Return on net tangible assets (%): -94.11563929278451
Capex to operating income (%): 0.3456619426201175
Buffett classification: The Great
Stock price: 73.58510638297874
P/E ratio: 18.141023857228618
Shares outstanding: 262136090
Book value: 7066808510.638298
P/B ratio: 2.7295648439362923
Market cap (USD): 19289312069.46809
Debt to equity: 0.7023694827482387
Current ratio: 2.044673264153211
Quick ratio: 1.5008213470090948
Effective tax rate (%): 27.745246873418633
Interest coverage ratio: 13.3195211786372
COGS to revenue (%): 50.27579921816918
R&D to revenue (%): 4.2856800249418425
SG&A to revenue (%): 24.63726407175576
Free cash flow (dilution-adjusted): 1096276595.744681
Buyback yield (%): 0.24597460158125103
Retained earnings: 6276914893.617022
Inventory turnover: 3.0887726536024753
Receivables turnover: 8.704101868280972
Capitalized R&D asset: 380212765.9574468
ROCI (R&D-adjusted, %): 13.723286116518826
FCF margin (%): 12.35700410101446
Rule of 40 score: 12.35700410101446
Financial ratios for LR.PA — annual report dated 2023-12-31
Total revenue: 9352111111.11111
Gross profit: 4887666666.666667
Operating income: 1768444444.4444444
Net income: 1276111111.1111112
Capital expenditures: 1888888.8888888888
Operating cash flow: 2040444444.4444444
Depreciation & amortization: 411222222.2222222
Net tangible assets: -1322666666.6666667
Owner earnings: 1685444444.4444447
Return on net tangible assets (%): -127.4277553763441
Capex to operating income (%): 0.10681075647147524
Buffett classification: The Great
Stock price: 98.74444444444444
P/E ratio: 20.28387837901611
Shares outstanding: 262136090
Book value: 7483000000
P/B ratio: 3.459104981409714
Market cap (USD): 25884482575.88889
Debt to equity: 0.7158893491915007
Current ratio: 1.9842128027681663
Quick ratio: 1.54364907727797
Effective tax rate (%): 25.884099122354154
Interest coverage ratio: 13.153719008264462
COGS to revenue (%): 47.73729045135383
R&D to revenue (%): 4.470767147049389
SG&A to revenue (%): 26.09274198339056
Free cash flow (dilution-adjusted): 1759000000
Buyback yield (%): 1.8861579357085385
Retained earnings: 6807222222.222222
Inventory turnover: 3.287245357113638
Receivables turnover: 8.678111145478914
Capitalized R&D asset: 672853664.3026005
ROCI (R&D-adjusted, %): 13.638930927439722
Rosenberg metric: 1.2526767394142875
FCF margin (%): 18.808587484703395
Revenue growth (%): 5.415071161527736
Rule of 40 score: 24.22365864623113
Financial ratios for LR.PA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 110.66666666666666
Shares outstanding: 262136090
Market cap (USD): 29009727293.333332
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LR.PA — quarterly report dated 2024-12-31
Total revenue: 2520729166.666667
Gross profit: 1270520833.3333335
Operating income: 471875000
Net income: 348958333.3333334
Capital expenditures: 1666666.6666666667
Operating cash flow: 679166666.6666667
Depreciation & amortization: 122187500
Net tangible assets: -2094895833.3333335
Owner earnings: 469479166.6666667
Return on net tangible assets (%): -22.41062105315499
Capex to operating income (%): 0.35320088300220753
Buffett classification: The Great
Stock price: 94.44791666666667
P/E ratio: 17.737223343507463
Shares outstanding: 262136090
Book value: 7862604166.666668
P/B ratio: 3.1488559081490703
Market cap (USD): 24758207583.645836
Debt to equity: 0.6738384494111099
Current ratio: 1.9261114346728794
Quick ratio: 1.4132401475441665
Effective tax rate (%): 23.200366804218252
Interest coverage ratio: 10.46189376443418
COGS to revenue (%): 49.597090788875576
R&D to revenue (%): 4.76465969668168
SG&A to revenue (%): 25.348154882433153
Free cash flow (dilution-adjusted): 562187500
Buyback yield (%): 0.00546956665619513
Retained earnings: 6958229166.666667
Inventory turnover: 0.9086229086229087
Receivables turnover: 2.3024738344433873
Capitalized R&D asset: 120104166.66666667
ROCI (R&D-adjusted, %): 3.891843190253743
FCF margin (%): 22.30257448654903
Rule of 40 score: 22.30257448654903
Financial ratios for LR.PA — annual report dated 2024-12-31
Total revenue: 9009270833.333334
Gross profit: 4652187500
Operating income: 1711145833.3333335
Net income: 1217604166.6666667
Capital expenditures: 7083333.333333334
Operating cash flow: 1586770833.3333335
Depreciation & amortization: 395520833.3333334
Net tangible assets: -2094895833.3333335
Owner earnings: 1606041666.6666667
Return on net tangible assets (%): -76.6645119586296
Capex to operating income (%): 0.41395263894807327
Buffett classification: The Great
Stock price: 94.44791666666667
P/E ratio: 20.33354374223629
Shares outstanding: 262136090
Book value: 7862604166.666668
P/B ratio: 3.1488559081490703
Market cap (USD): 24758207583.645836
Debt to equity: 0.6738384494111099
Current ratio: 1.9261114346728794
Quick ratio: 1.4132401475441665
Effective tax rate (%): 25.920527283097787
Interest coverage ratio: 10.673814165042236
COGS to revenue (%): 48.36221947299657
R&D to revenue (%): 4.695394790088913
SG&A to revenue (%): 26.33398466857057
Free cash flow (dilution-adjusted): 1337187500
Buyback yield (%): 0.1948007201398727
Retained earnings: 6958229166.666667
Inventory turnover: 3.1666288136876375
Receivables turnover: 8.229210275927688
Capitalized R&D asset: 828625490.5437354
ROCI (R&D-adjusted, %): 11.598264831798407
Rosenberg metric: -0.5631975817167162
FCF margin (%): 14.8423498942062
Revenue growth (%): -3.6659132222076902
Rule of 40 score: 11.176436671998509
Financial ratios for LR.PA — quarterly report dated 2025-03-31
Total revenue: 2475869565.217391
Gross profit: 1297826086.9565217
Operating income: 471956521.73913044
Net income: 319891304.34782606
Capital expenditures: 326086.95652173914
Operating cash flow: 240217391.3043478
Depreciation & amortization: 102065217.39130434
Net tangible assets: -2046413043.4782608
Owner earnings: 421630434.7826086
Return on net tangible assets (%): -20.60338875019918
Capex to operating income (%): 0.06909258406264394
Buffett classification: The Great
Stock price: 101.91304347826087
P/E ratio: 20.878253311586818
Shares outstanding: 262136090
Book value: 8242717391.304348
P/B ratio: 3.241053340682816
Market cap (USD): 26715086737.391304
Debt to equity: 0.7015283583664104
Current ratio: 1.9390568920791726
Quick ratio: 1.4479940300628977
Effective tax rate (%): 28.008806262230916
Interest coverage ratio: 11.456464379947231
COGS to revenue (%): 47.58099920976381
R&D to revenue (%): 4.565809114057425
SG&A to revenue (%): 26.850469751514623
Free cash flow (dilution-adjusted): 204130434.7826087
Buyback yield (%): 0.008951138251328003
Retained earnings: 7534239130.434782
Inventory turnover: 0.7842825095882481
Receivables turnover: 1.7810618500273672
Capitalized R&D asset: 193513269.92753625
ROCI (R&D-adjusted, %): 3.3750627487718927
Rosenberg metric: 0.22734643086089096
FCF margin (%): 8.244797611730618
Revenue growth (%): -1.779627976003344
Rule of 40 score: 6.465169635727275
Financial ratios for LR.PA — quarterly report dated 2025-06-30
Total revenue: 2937058823.529412
Gross profit: 1504000000
Operating income: 584470588.2352941
Net income: 394705882.3529412
Capital expenditures: 1176470.5882352942
Operating cash flow: 420000000
Depreciation & amortization: 123058823.52941176
Net tangible assets: -2416823529.4117646
Owner earnings: 516588235.2941176
Return on net tangible assets (%): -21.37467750571971
Capex to operating income (%): 0.20128824476650567
Buffett classification: The Great
Stock price: 131.4
P/E ratio: 32.38635085537951
Shares outstanding: 262136090
Book value: 8246117647.058823
P/B ratio: 4.177078681176169
Market cap (USD): 34444682226
Debt to equity: 0.8547480454260117
Current ratio: 2.1342610952878824
Quick ratio: 1.6256624725096442
Effective tax rate (%): 27.973379132674964
Interest coverage ratio: 12.837209302325581
COGS to revenue (%): 48.792309232926094
R&D to revenue (%): 4.053675145203284
SG&A to revenue (%): 25.40356499098738
Free cash flow (dilution-adjusted): 367647058.8235294
Buyback yield (%): 0.14720960994863433
Retained earnings: 7995764705.882353
Inventory turnover: 0.8634720351598497
Receivables turnover: 1.904707408255131
Capitalized R&D asset: 234432328.96419436
ROCI (R&D-adjusted, %): 3.561079921569573
Rosenberg metric: 1.823846153846154
FCF margin (%): 12.517524534348087
Revenue growth (%): 18.627364898018225
Rule of 40 score: 31.144889432366313
Financial ratios for LR.PA — annual report dated 2025-12-31
Total revenue: 11153647058.82353
Gross profit: 5668941176.470589
Operating income: 2127647058.8235295
Net income: 1473294117.647059
Capital expenditures: 3176470.588235294
Operating cash flow: 1855058823.5294118
Depreciation & amortization: 481294117.64705884
Net tangible assets: -3438588235.294118
Owner earnings: 1951411764.7058825
Return on net tangible assets (%): -56.75037635144382
Capex to operating income (%): 0.14929499585291675
Buffett classification: The Great
Stock price: 147.31764705882352
P/E ratio: 26.211515762836378
Shares outstanding: 262136090
Book value: 8628235294.117647
P/B ratio: 4.475686008971912
Market cap (USD): 38617271988
Debt to equity: 0.9004363239705482
Current ratio: 1.9309364490517629
Quick ratio: 1.422424851783795
Effective tax rate (%): 25.947608065756018
Interest coverage ratio: 10.771292435973793
COGS to revenue (%): 49.17410290487943
R&D to revenue (%): 4.31723730565576
SG&A to revenue (%): 25.826424487901612
Free cash flow (dilution-adjusted): 1562470588.235294
Buyback yield (%): 0.33876947458229845
Retained earnings: 8376117647.058824
Inventory turnover: 3.178564123542647
Receivables turnover: 7.727280136930476
Capitalized R&D asset: 902930036.7647059
ROCI (R&D-adjusted, %): 11.909066145733878
Rosenberg metric: 2.403554615640889
FCF margin (%): 14.008607050186697
Revenue growth (%): 23.801884360676944
Rule of 40 score: 37.81049141086364
Financial ratios for LR.PA — quarterly report dated 2025-12-31
Total revenue: 2952000000
Gross profit: 1453764705.882353
Operating income: 560000000
Net income: 421058823.5294118
Capital expenditures: 705882.3529411765
Operating cash flow: 677647058.8235295
Depreciation & amortization: 128117647.05882353
Net tangible assets: -3438588235.294118
Owner earnings: 548470588.2352942
Return on net tangible assets (%): -15.950458464486111
Capex to operating income (%): 0.12605042016806722
Buffett classification: The Great
Stock price: 147.31764705882352
P/E ratio: 26.01165222161814
Shares outstanding: 262136090
Book value: 8628235294.117647
P/B ratio: 4.475686008971912
Market cap (USD): 38617271988
Debt to equity: 0.9004363239705482
Current ratio: 1.9309364490517629
Quick ratio: 1.422424851783795
Effective tax rate (%): 20.23623802094941
Interest coverage ratio: 10.892448512585812
COGS to revenue (%): 50.7532281205165
R&D to revenue (%): 4.2682926829268295
SG&A to revenue (%): 24.784791965566715
Free cash flow (dilution-adjusted): 540235294.117647
Buyback yield (%): 0.205942594260462
Retained earnings: 8376117647.058824
Inventory turnover: 0.8682757210063409
Receivables turnover: 2.0451544543157554
Capitalized R&D asset: 243073759.59079286
ROCI (R&D-adjusted, %): 3.2291923700973437
Rosenberg metric: -0.4219367588932796
FCF margin (%): 18.30065359477124
Revenue growth (%): 0.5087121970759053
Rule of 40 score: 18.809365791847146
Financial ratios for MANH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 155.49
Shares outstanding: 59164602
Market cap (USD): 9199503964.980001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MANH — annual report dated 2022-12-31
Total revenue: 767084000
Gross profit: 408847000
Operating income: 152700000
Net income: 128959000
Capital expenditures: 6587000
Operating cash flow: 179630000
Depreciation & amortization: 6663000
Net tangible assets: 164570000
Owner earnings: 129035000
Return on net tangible assets (%): 78.40736464726257
Capex to operating income (%): 4.313686967910937
Buffett classification: The Great
Stock price: 121.4
P/E ratio: 55.69663755767338
Shares outstanding: 59164602
Book value: 226800000
P/B ratio: 31.66923581481482
Market cap (USD): 7182582682.8
Debt to equity: 0.06201499118165785
Current ratio: 1.3161647047640173
Quick ratio: 1.3161647047640173
Effective tax rate (%): 18.442838079698458
COGS to revenue (%): 46.701143551423314
R&D to revenue (%): 14.584713017088088
SG&A to revenue (%): 17.938974088887267
Free cash flow (dilution-adjusted): 113682000
Buyback yield (%): 2.8466083723563202
Retained earnings: 253711000
Receivables turnover: 4.5819584980945445
Capitalized R&D asset: 111877000
ROCI (R&D-adjusted, %): 62.021684949698916
FCF margin (%): 14.820019711009486
Rule of 40 score: 14.820019711009486
Financial ratios for MANH — annual report dated 2023-12-31
Total revenue: 928725000
Gross profit: 498111000
Operating income: 209881000
Net income: 176568000
Capital expenditures: 4730000
Operating cash flow: 246218000
Depreciation & amortization: 5752000
Net tangible assets: 216043000
Owner earnings: 177590000
Return on net tangible assets (%): 82.20122845914933
Capex to operating income (%): 2.2536580252619345
Buffett classification: The Great
Stock price: 215.32
P/E ratio: 72.14966529971456
Shares outstanding: 59164602
Book value: 278278000
P/B ratio: 45.77912052925491
Market cap (USD): 12739322102.64
Debt to equity: 0.06358389811627221
Current ratio: 1.3095664293620104
Quick ratio: 1.3095664293620104
Effective tax rate (%): 17.364546428855576
COGS to revenue (%): 46.36614713720423
R&D to revenue (%): 13.654634041293171
SG&A to revenue (%): 16.76104336590487
Free cash flow (dilution-adjusted): 169917000
Buyback yield (%): 1.5389123410214482
Retained earnings: 304701000
Receivables turnover: 5.087677491454115
Capitalized R&D asset: 201771590
ROCI (R&D-adjusted, %): 50.49616864704636
Rosenberg metric: 0.7978762390839941
FCF margin (%): 18.295728014213033
Revenue growth (%): 21.072138123073874
Rule of 40 score: 39.36786613728691
Financial ratios for MANH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 281.38
Shares outstanding: 59164602
Market cap (USD): 16647735710.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MANH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 270.24
Shares outstanding: 59164602
Market cap (USD): 15988642044.480001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MANH — annual report dated 2024-12-31
Total revenue: 1042352000
Gross profit: 571372000
Operating income: 261596000
Net income: 218364000
Capital expenditures: 8675000
Operating cash flow: 295003000
Depreciation & amortization: 6301000
Net tangible assets: 236900000
Owner earnings: 215990000
Return on net tangible assets (%): 91.1734909244407
Capex to operating income (%): 3.3161822046208655
Buffett classification: The Great
Stock price: 270.24
P/E ratio: 73.22013722261912
Shares outstanding: 59164602
Book value: 299126000
P/B ratio: 53.45119462861804
Market cap (USD): 15988642044.480001
Debt to equity: 0.1597788223023074
Current ratio: 1.2572045245613335
Quick ratio: 1.2572045245613335
Effective tax rate (%): 18.15871730868695
COGS to revenue (%): 45.18435231092759
R&D to revenue (%): 13.209453236526624
SG&A to revenue (%): 15.904991787802969
Free cash flow (dilution-adjusted): 193122000
Buyback yield (%): 1.791058922973802
Retained earnings: 329439000
Receivables turnover: 4.947818615933051
Capitalized R&D asset: 259573790
ROCI (R&D-adjusted, %): 44.392958933825824
Rosenberg metric: 0.5777043544088192
FCF margin (%): 18.527522372480696
Revenue growth (%): 12.234730409970657
Rule of 40 score: 30.762252782451355
Financial ratios for MANH — quarterly report dated 2025-03-31
Total revenue: 262787000
Gross profit: 148220000
Operating income: 66101000
Net income: 52582000
Capital expenditures: 891000
Operating cash flow: 75260000
Depreciation & amortization: 1541000
Net tangible assets: 182863000
Owner earnings: 53232000
Return on net tangible assets (%): 29.110317560140654
Capex to operating income (%): 1.347937247545423
Buffett classification: The Great
Stock price: 173.04
P/E ratio: 48.67560538815564
Shares outstanding: 59164602
Book value: 245095000
P/B ratio: 41.770916298088494
Market cap (USD): 10237842730.08
Debt to equity: 0.19175829780289275
Current ratio: 1.1242395362158533
Quick ratio: 1.1242395362158533
Effective tax rate (%): 18.488893022679008
COGS to revenue (%): 43.59690547858151
R&D to revenue (%): 13.432171302233368
SG&A to revenue (%): 17.230684927336586
Free cash flow (dilution-adjusted): 45543000
Buyback yield (%): 1.3327710104307666
Retained earnings: 274078000
Receivables turnover: 1.2472448195012673
Capitalized R&D asset: 35298000
ROCI (R&D-adjusted, %): 26.479233566615363
FCF margin (%): 17.33076598157443
Rule of 40 score: 17.33076598157443
Financial ratios for MANH — quarterly report dated 2025-06-30
Total revenue: 272421000
Gross profit: 156206000
Operating income: 73796000
Net income: 56780000
Capital expenditures: 3980000
Operating cash flow: 74050000
Depreciation & amortization: 1584000
Net tangible assets: 216515000
Owner earnings: 54384000
Return on net tangible assets (%): 25.117890215458516
Capex to operating income (%): 5.39324624640902
Buffett classification: The Great
Stock price: 197.47
P/E ratio: 106.83083664289241
Shares outstanding: 59164602
Book value: 278759000
P/B ratio: 41.9115937312876
Market cap (USD): 11683233956.94
Debt to equity: 0.1742903368142374
Current ratio: 1.1871010523989045
Quick ratio: 1.1871010523989045
Effective tax rate (%): 23.788303826691543
COGS to revenue (%): 42.66007392968971
R&D to revenue (%): 12.800408191732648
SG&A to revenue (%): 16.869110677958012
Free cash flow (dilution-adjusted): 45795000
Buyback yield (%): 0.429598518569303
Retained earnings: 304480000
Receivables turnover: 1.2982134262281801
Capitalized R&D asset: 58520660
ROCI (R&D-adjusted, %): 21.532523619814572
Rosenberg metric: 0.22624511303756586
FCF margin (%): 16.810378054555265
Revenue growth (%): 3.6660869829938316
Rule of 40 score: 20.476465037549097
Financial ratios for MANH — quarterly report dated 2025-09-30
Total revenue: 275795000
Gross profit: 155983000
Operating income: 75828000
Net income: 58633000
Capital expenditures: 5928000
Operating cash flow: 93110000
Depreciation & amortization: 1660000
Net tangible assets: 246972000
Owner earnings: 54365000
Return on net tangible assets (%): 22.012616814861605
Capex to operating income (%): 7.81769267289128
Buffett classification: The Great
Stock price: 204.98
P/E ratio: 72.19000635709395
Shares outstanding: 59164602
Book value: 309216000
P/B ratio: 39.220351204206764
Market cap (USD): 12127560117.96
Debt to equity: 0.154303140846528
Current ratio: 1.313085652634313
Quick ratio: 1.313085652634313
Effective tax rate (%): 25.243523051815586
COGS to revenue (%): 43.44241193640204
R&D to revenue (%): 13.18370528834823
SG&A to revenue (%): 15.27765187911311
Free cash flow (dilution-adjusted): 59605000
Buyback yield (%): 0.425056643699171
Retained earnings: 338690000
Receivables turnover: 1.2561487729781924
Capitalized R&D asset: 71371910
ROCI (R&D-adjusted, %): 17.435337794236155
Rosenberg metric: -0.006394998709529408
FCF margin (%): 21.612066933773274
Revenue growth (%): 1.2385241960054476
Rule of 40 score: 22.85059112977872
Financial ratios for MANH — quarterly report dated 2025-12-31
Total revenue: 270389000
Gross profit: 148644000
Operating income: 67012000
Net income: 51953000
Capital expenditures: 4658000
Operating cash flow: 147050000
Depreciation & amortization: 1532000
Net tangible assets: 252521000
Owner earnings: 48827000
Return on net tangible assets (%): 19.33581761516864
Capex to operating income (%): 6.9509938518474295
Buffett classification: The Great
Stock price: 173.31
P/E ratio: 46.61927897784931
Shares outstanding: 59164602
Book value: 314765000
P/B ratio: 32.57610335526504
Market cap (USD): 10253817172.62
Debt to equity: 0.1784823598557654
Current ratio: 1.2794941140085938
Quick ratio: 1.2794941140085938
Effective tax rate (%): 24.100803506208912
COGS to revenue (%): 45.02587013524958
R&D to revenue (%): 14.250949557859233
SG&A to revenue (%): 15.373036625010633
Free cash flow (dilution-adjusted): 111807000
Buyback yield (%): 0.7506960452302638
Retained earnings: 345097000
Receivables turnover: 1.2212581638828917
Capitalized R&D asset: 74401630
ROCI (R&D-adjusted, %): 15.06017024716898
Rosenberg metric: -0.20184268426842683
FCF margin (%): 41.35042475840363
Revenue growth (%): -1.9601515618484742
Rule of 40 score: 39.39027319655516
Financial ratios for MANH — annual report dated 2025-12-31
Total revenue: 1081392000
Gross profit: 609053000
Operating income: 282737000
Net income: 219948000
Capital expenditures: 15457000
Operating cash flow: 389470000
Depreciation & amortization: 6317000
Net tangible assets: 252521000
Owner earnings: 210808000
Return on net tangible assets (%): 83.48137382633524
Capex to operating income (%): 5.466918019219275
Buffett classification: The Great
Stock price: 173.31
P/E ratio: 46.61927897784931
Shares outstanding: 59164602
Book value: 314765000
P/B ratio: 32.57610335526504
Market cap (USD): 10253817172.62
Debt to equity: 0.1784823598557654
Current ratio: 1.2794941140085938
Quick ratio: 1.2794941140085938
Effective tax rate (%): 23.066591114189176
COGS to revenue (%): 43.678795478420405
R&D to revenue (%): 13.414377025167562
SG&A to revenue (%): 16.17701998905115
Free cash flow (dilution-adjusted): 262750000
Buyback yield (%): 3.073606586643201
Retained earnings: 345097000
Receivables turnover: 4.884291921482191
Capitalized R&D asset: 279162250
ROCI (R&D-adjusted, %): 43.957283315016376
Rosenberg metric: 0.2736674679894545
FCF margin (%): 24.297387071478244
Revenue growth (%): 3.7453758423258168
Rule of 40 score: 28.04276291380406
Financial ratios for MARKOLINES.NS — quarterly report dated 2025-12-31
Total revenue: 10354650.774200736
Gross profit: 8414704.244179571
Operating income: 915339.2001782333
Net income: 779414.058148602
Capital expenditures: 0
Depreciation & amortization: 209535.47955887267
Owner earnings: 988949.5377074747
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.8342430656121198
P/E ratio: 12.958688149734929
Shares outstanding: 22040920
Market cap (USD): 40428404.669711486
Effective tax rate (%): 19.464593102629546
Interest coverage ratio: 6.269169146257726
COGS to revenue (%): 18.735026147426083
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 18.248822435948945
Rule of 40 score: 18.248822435948945
Financial ratios for MDLZ — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 58.74
Shares outstanding: 1283649766
Market cap (USD): 75401587254.84
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MDLZ — annual report dated 2022-12-31
Total revenue: 31496000000
Gross profit: 11312000000
Operating income: 3796000000
Net income: 2726000000
Capital expenditures: 45000000
Operating cash flow: 3908000000
Depreciation & amortization: 1107000000
Net tangible assets: -16277000000
Owner earnings: 3788000000
Return on net tangible assets (%): -23.272101738649628
Capex to operating income (%): 1.1854583772391991
Buffett classification: The Great
Stock price: 60.45
P/E ratio: 28.465380907813646
Shares outstanding: 1283649766
Book value: 26920000000
P/B ratio: 2.8824899091641902
Market cap (USD): 77596628354.7
Debt to equity: 0.8709881129271917
Current ratio: 0.6031319108242185
Quick ratio: 0.40105193951347795
Effective tax rate (%): 26.796778190830235
Interest coverage ratio: 8.869158878504672
COGS to revenue (%): 64.08432816865634
SG&A to revenue (%): 23.444246888493776
Free cash flow (dilution-adjusted): 2882000000
Buyback yield (%): 2.5993397429333425
Retained earnings: 31481000000
Inventory turnover: 5.9698314108252
Receivables turnover: 8.06142820578449
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.974095168105824
FCF margin (%): 9.150368300736602
Rule of 40 score: 9.150368300736602
Financial ratios for MDLZ — annual report dated 2023-12-31
Total revenue: 36016000000
Gross profit: 13764000000
Operating income: 5611000000
Net income: 4968000000
Capital expenditures: 19000000
Operating cash flow: 4714000000
Depreciation & amortization: 1215000000
Net tangible assets: -15400000000
Owner earnings: 6164000000
Return on net tangible assets (%): -40.02597402597402
Capex to operating income (%): 0.33862056674389596
Buffett classification: The Great
Stock price: 67.21
P/E ratio: 17.365962313377615
Shares outstanding: 1283649766
Book value: 28366000000
P/B ratio: 3.0414616362144815
Market cap (USD): 86274100772.85999
Debt to equity: 0.703130508355073
Current ratio: 0.615526218902856
Quick ratio: 0.42539315205385786
Effective tax rate (%): 26.139455782312925
Interest coverage ratio: 10.201818181818181
COGS to revenue (%): 61.78365171035095
SG&A to revenue (%): 22.21790315415371
Free cash flow (dilution-adjusted): 3456000000
Buyback yield (%): 1.7931221376307334
Retained earnings: 34236000000
Inventory turnover: 6.155463347164592
Receivables turnover: 7.9822695035460995
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.71251288709
FCF margin (%): 9.595735228787206
Revenue growth (%): 14.351028702057404
Rule of 40 score: 23.94676393084461
Financial ratios for MDLZ — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 69.66
Shares outstanding: 1283649766
Market cap (USD): 89419042699.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MDLZ — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 56.93
Shares outstanding: 1283649766
Market cap (USD): 73078181178.38
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MDLZ — annual report dated 2024-12-31
Total revenue: 36441000000
Gross profit: 14257000000
Operating income: 6665000000
Net income: 4623000000
Capital expenditures: 16000000
Operating cash flow: 4910000000
Depreciation & amortization: 1302000000
Net tangible assets: -14933000000
Owner earnings: 5909000000
Return on net tangible assets (%): -39.57007968927878
Capex to operating income (%): 0.24006001500375096
Buffett classification: The Great
Stock price: 56.93
P/E ratio: 15.807523508193814
Shares outstanding: 1283649766
Book value: 26958000000
P/B ratio: 2.710816127990949
Market cap (USD): 73078181178.38
Debt to equity: 0.6815045626530158
Current ratio: 0.6773748017801422
Quick ratio: 0.48161031254795644
Effective tax rate (%): 23.462705638076983
Interest coverage ratio: 13.12007874015748
COGS to revenue (%): 60.876485277571966
SG&A to revenue (%): 20.413819598803546
Free cash flow (dilution-adjusted): 3376000000
Buyback yield (%): 3.1938397512970775
Retained earnings: 36476000000
Inventory turnover: 5.796707603867259
Receivables turnover: 7.574516732488048
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.616490970008991
FCF margin (%): 9.264290222551521
Revenue growth (%): 1.1800310972900934
Rule of 40 score: 10.444321319841615
Financial ratios for MDLZ — quarterly report dated 2025-03-31
Total revenue: 9313000000
Gross profit: 2430000000
Operating income: 682000000
Net income: 407000000
Capital expenditures: 1000000
Operating cash flow: 1092000000
Depreciation & amortization: 324000000
Net tangible assets: -16784000000
Owner earnings: 730000000
Return on net tangible assets (%): -4.349380362249762
Capex to operating income (%): 0.1466275659824047
Buffett classification: The Great
Stock price: 65.12
P/E ratio: 51.345990640000004
Shares outstanding: 1283649766
Book value: 25823000000
P/B ratio: 3.237086038102467
Market cap (USD): 83591272761.92001
Debt to equity: 0.7805057506873717
Current ratio: 0.6061038899204876
Quick ratio: 0.40351378374517927
Effective tax rate (%): 28.256880733944957
Interest coverage ratio: 4.978102189781022
COGS to revenue (%): 73.90744121121014
SG&A to revenue (%): 18.37216793729196
Free cash flow (dilution-adjusted): 797000000
Buyback yield (%): 1.820764237356303
Retained earnings: 36263000000
Inventory turnover: 1.617626321974148
Receivables turnover: 1.7708689864993346
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.423086553710041
FCF margin (%): 8.557929775582519
Rule of 40 score: 8.557929775582519
Financial ratios for MDLZ — quarterly report dated 2025-06-30
Total revenue: 8984000000
Gross profit: 2937000000
Operating income: 1174000000
Net income: 644000000
Capital expenditures: 7000000
Operating cash flow: 308000000
Depreciation & amortization: 339000000
Net tangible assets: -17880000000
Owner earnings: 976000000
Return on net tangible assets (%): -5.458612975391499
Capex to operating income (%): 0.596252129471891
Buffett classification: The Great
Stock price: 65.18
P/E ratio: 79.60826997895339
Shares outstanding: 1283649766
Book value: 26247000000
P/B ratio: 3.187727806906694
Market cap (USD): 83668291747.88
Debt to equity: 0.8193317331504553
Current ratio: 0.6412513202233063
Quick ratio: 0.39224463109188756
Effective tax rate (%): 26.900584795321635
Interest coverage ratio: 7.774834437086093
COGS to revenue (%): 67.30854853072128
SG&A to revenue (%): 19.20080142475512
Free cash flow (dilution-adjusted): -44000000
Buyback yield (%): 0.1565706640632104
Retained earnings: 36293000000
Inventory turnover: 1.2213694203191274
Receivables turnover: 1.9399697689483912
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2957936523456595
FCF margin (%): -0.4897595725734639
Revenue growth (%): -3.5326962310748415
Rule of 40 score: -4.022455803648305
Financial ratios for MDLZ — quarterly report dated 2025-09-30
Total revenue: 9744000000
Gross profit: 2612000000
Operating income: 785000000
Net income: 746000000
Capital expenditures: 0
Operating cash flow: 717000000
Depreciation & amortization: 343000000
Net tangible assets: -17684000000
Owner earnings: 1089000000
Return on net tangible assets (%): -6.158109025107442
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 60.86
P/E ratio: 43.47408166875904
Shares outstanding: 1283649766
Book value: 26229000000
P/B ratio: 2.978494214753136
Market cap (USD): 78122924758.76
Debt to equity: 0.8362118266041405
Current ratio: 0.6111472666418744
Quick ratio: 0.3741632577166233
Effective tax rate (%): 19.71223021582734
Interest coverage ratio: 5
COGS to revenue (%): 73.19376026272579
SG&A to revenue (%): 18.421592775041052
Free cash flow (dilution-adjusted): 399000000
Buyback yield (%): 0.30720816039735965
Retained earnings: 36390000000
Inventory turnover: 1.3989799921537858
Receivables turnover: 1.8602520045819015
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5748505396621597
FCF margin (%): 4.094827586206897
Revenue growth (%): 8.459483526268922
Rule of 40 score: 12.554311112475819
Financial ratios for MDLZ — annual report dated 2025-12-31
Total revenue: 38537000000
Gross profit: 10935000000
Operating income: 3620000000
Net income: 2466000000
Capital expenditures: 9000000
Operating cash flow: 4514000000
Depreciation & amortization: 1358000000
Net tangible assets: -18126000000
Owner earnings: 3815000000
Return on net tangible assets (%): -21.047114641950788
Capex to operating income (%): 0.24861878453038672
Buffett classification: The Great
Stock price: 52.92
P/E ratio: 27.546936584233578
Shares outstanding: 1283649766
Book value: 25891000000
P/B ratio: 2.6237204285937197
Market cap (USD): 67930745616.72
Debt to equity: 0.8421459194314627
Current ratio: 0.5923435784851812
Quick ratio: 0.3902305159165752
Effective tax rate (%): 25.94558725945587
Interest coverage ratio: 6.043405676126878
COGS to revenue (%): 71.6246723927654
SG&A to revenue (%): 18.613280743181875
Free cash flow (dilution-adjusted): 3121000000
Buyback yield (%): 3.5109286352555107
Retained earnings: 36413000000
Inventory turnover: 6.246209549671871
Receivables turnover: 7.932688349114862
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.295004332668318
FCF margin (%): 8.098710330331889
Revenue growth (%): 5.751763123953788
Rule of 40 score: 13.850473454285677
Financial ratios for MDLZ — quarterly report dated 2025-12-31
Total revenue: 10496000000
Gross profit: 2956000000
Operating income: 979000000
Net income: 669000000
Capital expenditures: 1000000
Operating cash flow: 2397000000
Depreciation & amortization: 352000000
Net tangible assets: -18126000000
Owner earnings: 1020000000
Return on net tangible assets (%): -5.6272757365110895
Capex to operating income (%): 0.10214504596527069
Buffett classification: The Great
Stock price: 52.92
P/E ratio: 27.546936584233578
Shares outstanding: 1283649766
Book value: 25891000000
P/B ratio: 2.6237204285937197
Market cap (USD): 67930745616.72
Debt to equity: 0.8421459194314627
Current ratio: 0.5923435784851812
Quick ratio: 0.3902305159165752
Effective tax rate (%): 28.40043525571273
Interest coverage ratio: 6.357142857142857
COGS to revenue (%): 71.83689024390245
SG&A to revenue (%): 18.502286585365855
Free cash flow (dilution-adjusted): 1969000000
Buyback yield (%): 0.7242670392225204
Retained earnings: 36413000000
Inventory turnover: 1.7062683865127857
Receivables turnover: 2.160559901193907
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.972875481127703
FCF margin (%): 18.75952743902439
Revenue growth (%): 7.717569786535304
Rule of 40 score: 26.477097225559692
Financial ratios for MPAA — annual report dated 2022-03-31
Total revenue: 650308000
Gross profit: 117865000
Operating income: 27031000
Net income: 7361000
Capital expenditures: 7550000
Operating cash flow: -44862000
Depreciation & amortization: 12886000
Net tangible assets: 308259000
Owner earnings: 12697000
Return on net tangible assets (%): 4.11893894419952
Capex to operating income (%): 27.930894158558694
Buffett classification: The Good
Stock price: 17.83
P/E ratio: 45.84017184349952
Shares outstanding: 18924818
Book value: 315263000
P/B ratio: 1.0703111527201097
Market cap (USD): 337429504.93999994
Debt to equity: 0.8224403117397221
Current ratio: 1.2593309177894256
Quick ratio: 0.35525146281117714
Effective tax rate (%): 44.0185565442239
Interest coverage ratio: 1.737769206043073
COGS to revenue (%): 81.8755112961858
R&D to revenue (%): 1.614927080706373
SG&A to revenue (%): 12.352915849105347
Free cash flow (dilution-adjusted): -59699000
Buyback yield (%): 0.567229590767511
Retained earnings: 92954000
Inventory turnover: 1.3811607661658505
Receivables turnover: 5.761260143874694
Capitalized R&D asset: 10502000
ROCI (R&D-adjusted, %): 5.673994170230385
FCF margin (%): -9.180111577898472
Rule of 40 score: -9.180111577898472
Financial ratios for MPAA — annual report dated 2023-03-31
Total revenue: 683074000
Gross profit: 113962000
Operating income: 27155000
Net income: -4207000
Capital expenditures: 4201000
Operating cash flow: -21754000
Depreciation & amortization: 12444000
Net tangible assets: 315127000
Owner earnings: 4036000
Capex to operating income (%): 15.470447431412262
Buffett classification: The Great
Stock price: 7.44
Shares outstanding: 18924818
Book value: 320475000
P/B ratio: 0.43934985855370934
Market cap (USD): 140800645.92000002
Debt to equity: 0.8650347140962633
Current ratio: 1.4048333472733356
Quick ratio: 0.47367430578788894
Interest coverage ratio: 0.6865124510175705
COGS to revenue (%): 83.31630247967277
R&D to revenue (%): 1.5111100700656153
SG&A to revenue (%): 11.197176294222881
Free cash flow (dilution-adjusted): -30640000
Buyback yield (%): 0
Retained earnings: 88747000
Inventory turnover: 1.597489431697609
Receivables turnover: 4.632046491757478
Capitalized R&D asset: 17358340
ROCI (R&D-adjusted, %): 4.603380667445423
Rosenberg metric: -0.37164349647686157
FCF margin (%): -4.485604780741179
Revenue growth (%): 5.0385355862145325
Rule of 40 score: 0.5529308054733537
Financial ratios for MPAA — annual report dated 2024-03-31
Total revenue: 717684000
Gross profit: 132551000
Operating income: 42306000
Net income: -49244000
Capital expenditures: 1000000
Operating cash flow: 39172000
Depreciation & amortization: 11619000
Net tangible assets: 280836000
Owner earnings: -38625000
Return on net tangible assets (%): -13.753578601034055
Capex to operating income (%): 2.3637309128728785
Buffett classification: The Great
Stock price: 8.04
Shares outstanding: 18924818
Book value: 285110000
P/B ratio: 0.5336730971204097
Market cap (USD): 152155536.71999997
Debt to equity: 0.8394479323769773
Current ratio: 1.3858169005378005
Quick ratio: 0.4033652716820177
Interest coverage ratio: 0.7046302465023317
COGS to revenue (%): 81.53072940179801
R&D to revenue (%): 1.3926742131634535
SG&A to revenue (%): 11.181801461367398
Free cash flow (dilution-adjusted): 33472000
Buyback yield (%): 0
Retained earnings: 39503000
Inventory turnover: 1.472669935166915
Receivables turnover: 5.558357471460215
Capitalized R&D asset: 20376400
ROCI (R&D-adjusted, %): 6.692853323192454
Rosenberg metric: 1.8009106762255376
FCF margin (%): 4.66389107183663
Revenue growth (%): 5.066800961535646
Rule of 40 score: 9.730692033372277
Financial ratios for MPAA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.39
Shares outstanding: 18924818
Market cap (USD): 139854405.01999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MPAA — quarterly report dated 2024-12-31
Total revenue: 186176000
Gross profit: 44882000
Operating income: 20041000
Net income: 2291000
Capital expenditures: 620000
Operating cash flow: 34357000
Depreciation & amortization: 2532000
Net tangible assets: 258825000
Owner earnings: 4203000
Return on net tangible assets (%): 1.6238771370617213
Capex to operating income (%): 3.0936580010977495
Buffett classification: The Great
Stock price: 7.6
P/E ratio: 15.694960366652117
Shares outstanding: 18924818
Book value: 262671000
P/B ratio: 0.5475618427614772
Market cap (USD): 143828616.79999998
Debt to equity: 0.774048143875799
Current ratio: 1.4466095447361098
Quick ratio: 0.3937798864637088
Effective tax rate (%): 32.736347621843805
Interest coverage ratio: 1.388361621059924
COGS to revenue (%): 75.89270367823995
R&D to revenue (%): 1.615675489859058
SG&A to revenue (%): 11.727075455482984
Free cash flow (dilution-adjusted): 32695000
Buyback yield (%): 1.4572899653999871
Retained earnings: 20755000
Inventory turnover: 0.3849679043560709
Receivables turnover: 1.785809521068938
Capitalized R&D asset: 3008000
ROCI (R&D-adjusted, %): 3.650629376033206
FCF margin (%): 17.561339807493983
Rule of 40 score: 17.561339807493983
Financial ratios for MPAA — quarterly report dated 2025-03-31
Total revenue: 193105000
Gross profit: 38495000
Operating income: 13204000
Net income: -722000
Capital expenditures: 2862000
Operating cash flow: 9109000
Depreciation & amortization: 2538000
Net tangible assets: 253942000
Owner earnings: -1046000
Return on net tangible assets (%): -0.41190508068771603
Capex to operating income (%): 21.675249924265376
Buffett classification: The Great
Stock price: 9.5
Shares outstanding: 18924818
Book value: 257699000
P/B ratio: 0.6976580079860613
Market cap (USD): 179785771
Debt to equity: 0.7810818047411903
Current ratio: 1.457078555658429
Quick ratio: 0.4324535289509294
Effective tax rate (%): 159.57095709570956
Interest coverage ratio: 1.0524469950581858
COGS to revenue (%): 80.06524947567387
R&D to revenue (%): 1.8233603479972036
SG&A to revenue (%): 11.273659408094042
Free cash flow (dilution-adjusted): 5379000
Buyback yield (%): 1.5218112005092994
Retained earnings: 20033000
Inventory turnover: 0.42986746147151966
Receivables turnover: 1.5463492368551706
Capitalized R&D asset: 5536360
ROCI (R&D-adjusted, %): 2.376660852816006
Rosenberg metric: -2.1233377659574466
FCF margin (%): 2.7855311876958133
Revenue growth (%): 3.721747163973874
Rule of 40 score: 6.5072783516696875
Financial ratios for MPAA — annual report dated 2025-03-31
Total revenue: 757354000
Gross profit: 153828000
Operating income: 55815000
Net income: -19470000
Capital expenditures: 4529000
Operating cash flow: 45477000
Depreciation & amortization: 10400000
Net tangible assets: 253942000
Owner earnings: -13599000
Return on net tangible assets (%): -5.355159839648423
Capex to operating income (%): 8.114306190092268
Buffett classification: The Great
Stock price: 9.5
Shares outstanding: 18924818
Book value: 257699000
P/B ratio: 0.6976580079860613
Market cap (USD): 179785771
Debt to equity: 0.7810818047411903
Current ratio: 1.457078555658429
Quick ratio: 0.4324535289509294
Interest coverage ratio: 1.0047704770477048
COGS to revenue (%): 79.68875849338617
R&D to revenue (%): 1.5059008072843083
SG&A to revenue (%): 11.435603429835982
Free cash flow (dilution-adjusted): 37022000
Buyback yield (%): 2.687643172829289
Retained earnings: 20033000
Inventory turnover: 1.6780039425138114
Receivables turnover: 6.0647511971684365
Capitalized R&D asset: 21507910
ROCI (R&D-adjusted, %): 9.018356094389834
Rosenberg metric: 2.1287643821910955
FCF margin (%): 4.888334913395849
Revenue growth (%): 5.527502354796819
Rule of 40 score: 10.415837268192668